This inventor holds 3 USPTO granted patents. Top assignee: The Hong Kong Polytechnic University. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Innovations of Johnny Cheuk-on Tang in Anti-Cancer Research
Introduction
Johnny Cheuk-on Tang is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of anti-cancer research, holding a total of three patents. His work focuses on developing quinoline derivatives that show promising anticancer activities against various cancer cell lines.
Latest Patents
Among his latest patents, one is titled "Quinoline derivatives as anti-cancer agents." This invention highlights quinoline derivatives that exhibit anticancer activities against cancer cell lines, including hepatocellular carcinoma (Hep3B), lung carcinoma (A549), and esophageal squamous cell carcinoma (HKESC-1, HKESC-4, and KYSE150). Another patent is "Method of making and administering quinoline derivatives as anti-cancer agents." This invention relates to methods for preparing quinoline derivative compounds and administering them in the treatment of both solid and non-solid tumors, with a particular focus on liver cancer.
Career Highlights
Johnny Cheuk-on Tang is affiliated with The Hong Kong Polytechnic University, where he continues to advance his research in the field of cancer treatment. His innovative approaches and dedication to scientific inquiry have positioned him as a key figure in his area of expertise.
Collaborations
He has collaborated with notable colleagues, including Sau Hing Chan and Albert Sun-chi Chan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Johnny Cheuk-on Tang's work in developing quinoline derivatives as anti-cancer agents showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patents reflect the potential for significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
